Home Elan in $1 billion royalty deal with Theravance
 

Keywords :   


Elan in $1 billion royalty deal with Theravance

2013-05-13 09:42:52| Biotech - Topix.net

Elan will make a once off payment of $1 billion to the company in exchange for a 21% stake in future royalty payments from four respiratory programmes which Theravance has developed with GlaxosmithKline.

Tags: with deal billion royalty

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
29.06Eastern North Pacific Tropical Weather Outlook
29.06Atlantic Tropical Weather Outlook
29.06Tropical Storm Beryl Graphics
29.06Tropical Storm Beryl Forecast Discussion Number 2
29.06Tropical Storm Beryl Public Advisory Number 2
29.06Summary for Tropical Storm Beryl (AT2/AL022024)
29.06Tropical Storm Beryl Wind Speed Probabilities Number 2
29.06Tropical Storm Beryl Forecast Advisory Number 2
More »